Back
Benitec Biopharma 10K Form
Buy
58
BNTC
Benitec Biopharma
Last Price:
8.03
Seasonality Move:
-15.52%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-13 | 10Q | BNTC/Benitec Biopharma Quarterly |
| 2023-05-15 | 10Q | BNTC/Benitec Biopharma Quarterly |
| 2023-02-13 | 10Q | BNTC/Benitec Biopharma Quarterly |
| 2022-11-10 | 10Q | BNTC/Benitec Biopharma Quarterly |
| 2022-05-16 | 10Q | BNTC/Benitec Biopharma Quarterly |
| 2022-02-14 | 10Q | BNTC/Benitec Biopharma Quarterly |
Receive BNTC News And Ratings
See the #1 stock for the next 7 days that we like better than BNTC
BNTC Financial Statistics
Sales & Book Value
| Annual Sales: | $75K |
|---|---|
| Cash Flow: | $-5.37M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $5.97 |
| Price / Book: | 1.4 |
Profitability
| EPS (TTM): | -10.95180 |
|---|---|
| Net Income (TTM): | $-21.81M |
| Gross Margin: | $75K |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Benitec Biopharma Earnings Forecast
Key Benitec Biopharma Financial Ratios
- The Gross Profit Margin over the past 11 years for BNTC is 100.00%.
- The Selling, General & Administrative Expenses for BNTC have been equal to 8,509.33% of Gross Profit Margin.
- The Research & Development expenses have been 17,032.00% of Revenue.
- The Interest Expense is -0.17% of Operating Income.
- The Net Earning history of BNTC is -26,082.67% of Total Revenues.
- Per Share Earnings over the last 11 years have been positive in 5 years.
Benitec Biopharma Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | BNTC |
| CUSIP: | 08205P |
| Website: | benitec.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
BNTC Technical Analysis vs Fundamental Analysis
Buy
58
Benitec Biopharma (BNTC)
is a Buy
Is Benitec Biopharma a Buy or a Sell?
-
Benitec Biopharma stock is rated a Buy
The current Benitec Biopharma [BNTC] share price is $8.37. The Score for BNTC is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.